Med Tech Company Opposes Review Of Overturned $340M Antitrust Award
WASHINGTON, D.C. — In a dispute over entitlement to a treble damages award for attempted monopolization under Section 2 of the Sherman Act, a medical technology company argues in a Feb....To view the full article, register now.
Already a subscriber? Click here to view full article